SPAC and De-SPAC Transactions:
A Legal Guide for Sponsors and Target Companies

1. SPAC Market Cycle Overview

The SPAC market has passed through two distinct phases since 2019, and understanding each phase is essential to evaluating the current legal and transactional environment. The 2020 and 2021 SPAC boom produced hundreds of blank-check IPOs, with sponsors and targets operating under a disclosure regime that permitted management projections in Form S-4 filings with relatively limited Securities Act liability. Low interest rates kept trust account opportunity costs low, redemption rates were moderate, and PIPE financing flowed easily from hedge funds and crossover investors who viewed SPAC exposure as optionality rather than committed capital. The combined result was a transaction structure that allowed private companies to reach public markets in six to nine months with forward projections that would not survive the scrutiny of a traditional S-1.

The 2022 correction fundamentally changed the SPAC market. Rising interest rates increased the relative attractiveness of trust account redemption at par, and redemption rates climbed above 80 percent on a substantial portion of announced transactions. Target companies that had signed business combination agreements at premium valuations found themselves entering the public market with minimal cash, heavily diluted cap tables, and stock prices that quickly fell below $10. SPAC litigation followed, with plaintiff firms targeting warrant accounting, management projections, and sponsor conflicts of interest.

The post-2022 SPAC market is a more selective and legally demanding environment. The SEC's 2024 SPAC Rules, effective July 2024, codified the Commission's view that de-SPAC transactions should be subject to disclosure and liability standards equivalent to traditional IPOs. Deal volume has declined significantly from peak levels, but the transactions that do close tend to be more structurally sophisticated, with promote adjustments, non-redemption agreements, and PIPE arrangements that reflect the lessons of the correction period. For sponsors and target companies approaching a SPAC transaction in 2025 or 2026, the legal framework is more rigorous than at any prior point in the SPAC market's history.

2. SPAC IPO Mechanics: Units, Class A Shares, and Public Warrants

A SPAC conducts its IPO by selling units to public investors, typically at $10 per unit. Each unit consists of one Class A common share and a fraction of a redeemable public warrant, with the warrant fraction commonly set at one-half or one-third of a whole warrant so that a complete warrant requires the purchase of two or three units. The Class A shares represent the economic interest of public shareholders and carry the redemption right that allows holders to exchange their shares for their pro-rata trust account proceeds if they elect not to participate in the business combination. The warrants are exercisable after the de-SPAC transaction closes, typically at an exercise price of $11.50 per share, and represent the equity upside component of the unit that compensates investors for the time value risk of holding trust proceeds during the search period.

Following the SPAC IPO, the units typically trade as units for 52 days before separating into Class A shares and whole warrants that trade independently on the relevant exchange. This separation mechanics creates two distinct trading populations: shareholders who seek the safety of the trust redemption put and hold Class A shares, and warrant holders who are seeking levered equity exposure to the eventual business combination without any redemption right. The relationship between the trading price of the Class A shares and the warrant price is therefore a real-time indicator of market confidence in the SPAC's ability to complete a business combination at or above $10 per share.

The legal documentation for a SPAC IPO consists of an underwriting agreement with the SPAC's underwriters, a trust agreement governing the deposit and investment of trust proceeds, a warrant agreement establishing the terms of the public warrants, and the SPAC's IPO registration statement on Form S-1. The sponsor simultaneously executes a private placement warrant purchase agreement, a letter agreement governing founder share and private placement warrant transfer restrictions, and a registration rights agreement covering the resale of founder shares and private placement warrants following the de-SPAC. Each of these documents imposes obligations on the sponsor that survive through the de-SPAC transaction closing and must be reviewed by target counsel during due diligence.

3. Sponsor Promote Structure: Founder Shares, Forfeiture, and Recycling

The sponsor's promote is the defining economic feature of the SPAC structure and the primary source of misaligned incentives that regulators and courts have scrutinized. At formation, the sponsor purchases founder shares in the SPAC for nominal consideration, typically $25,000 for a share count equal to 20 percent of the post-IPO Class A share count. Because the SPAC will issue 80 percent of its post-IPO shares to the public at $10 per share, the sponsor's founder shares, acquired at a fraction of a cent per share, will represent 20 percent of the fully diluted equity if the SPAC completes a business combination at any positive enterprise value. This structure means the sponsor profits on any closed deal, even one where public shareholders lose money, absent a promote forfeiture or adjustment mechanism.

In the post-2022 market, founders shares are increasingly subject to forfeiture provisions that reduce the sponsor's economic interest if the business combination closes at a price that does not benefit public shareholders. A common structure requires the sponsor to place a portion of founder shares (often 20 to 30 percent) in escrow at closing, with release contingent on the combined company's stock reaching specified volume-weighted average price thresholds during a defined measurement period, typically three to five years after closing. Shares that do not vest within the measurement period are forfeited and either returned to the combined company for cancellation or recycled into an employee equity reserve.

From a target company negotiating perspective, the founder share structure and any forfeiture mechanics should be analyzed as part of the overall cap table model that determines post-closing ownership and dilution. A SPAC that enters the de-SPAC negotiation with 20 percent founder shares that vest immediately upon closing imposes a different dilution burden than one where 30 percent of founder shares are subject to price hurdles above $12.50 per share. Target counsel should request and model the full pro forma cap table including founder shares, public shares expected to remain after redemptions, PIPE shares, private placement warrants, public warrants, and any earnout shares issued to target shareholders, before advising the target's board on whether the transaction economics are appropriate.

4. Sponsor At-Risk Capital: Private Placement Warrants and Sponsor Investment

Alongside the founder share promote, sponsors invest at-risk capital in the SPAC through the purchase of private placement warrants at $1.50 per warrant, with proceeds used to fund a portion of the SPAC's operating costs during the search period and to supplement the trust account so that redemption proceeds remain at $10 per share even after underwriting commissions are deducted. Private placement warrants are structurally identical to public warrants in their exercise terms, but they are not redeemable by the SPAC and are subject to transfer restrictions that prevent the sponsor from selling them until 30 days after the de-SPAC closing. The private placement warrant purchase is the primary form of at-risk capital the sponsor commits to the SPAC, because unlike the founder shares purchased for nominal consideration, the private placement warrants represent cash invested in a security that has no value if the SPAC fails to complete a business combination.

Some SPAC structures supplement the private placement warrant investment with a forward purchase agreement, in which the sponsor or an affiliated fund commits to purchase additional Class A shares at $10 per share at the time of the de-SPAC closing. Forward purchase agreements provide the SPAC with committed capital to offset redemptions without requiring a separate PIPE process and signal sponsor confidence in the ultimate target, but they also create potential conflicts of interest when the sponsor's affiliated fund evaluates the business combination at the same time the sponsor is negotiating deal terms with the target.

Target companies should carefully evaluate the total economics of the sponsor's investment, including the relationship between at-risk capital (private placement warrant purchase price) and the promote (founder shares acquired for nominal consideration), to assess whether the sponsor's incentives are sufficiently aligned with public investor interests. A sponsor who has invested $10 million in private placement warrants and holds $25 million in founder shares at a post-IPO share count that implies a $100 million market capitalization has a materially different risk profile than a sponsor whose at-risk capital represents a small fraction of the promote value. This analysis informs how aggressively the target should negotiate for promote adjustments and forfeiture provisions in the business combination agreement.

5. Trust Account Mechanics: IPO Proceeds, Interest Accrual, and Redemption Rights

The trust account is the structural feature that distinguishes a SPAC from a typical blank-check company and gives public shareholders their principal protection. Substantially all of the gross IPO proceeds, net of the underwriting discount allocable to the IPO closing (the deferred underwriting commission is held in trust until the de-SPAC closes), are deposited into a trust account established pursuant to the trust agreement and invested in U.S. Treasury bills, government money market funds, or similar low-risk instruments. The trust agreement specifies that proceeds may be withdrawn only to fund the redemption of Class A shares in connection with the shareholder vote or extension vote, to fund the business combination at closing after all redemptions are processed, or to be returned to shareholders in full if no business combination is completed within the deadline.

Interest accrued on trust investments is added to the per-share redemption amount over time, meaning that shareholders who hold Class A shares through a lengthy search period and then elect to redeem at the shareholder vote receive slightly more than $10 per share depending on prevailing interest rates. In the 2021 and 2022 period, when interest rates were low, trust interest was immaterial. Following the Federal Reserve's rate increases beginning in 2022, trust accounts began generating meaningful interest income, which paradoxically increased the attractiveness of the redemption option relative to holding shares in the combined company at a potentially depressed market price.

A public shareholder's redemption right is contractual, not statutory, and is exercisable at the shareholder's election regardless of how the shareholder votes on the business combination. This separation of voting rights from redemption rights is a defining feature of SPAC structures that differs from traditional merger appraisal rights. A shareholder can vote in favor of the business combination and simultaneously tender shares for redemption, or vote against the combination while retaining their shares. This optionality created significant arbitrage behavior in the SPAC market, where holders, including hedge funds, purchased units in the aftermarket below $10, locked in a trust redemption return, and held warrants as a free call option on the business combination's success.

6. SPAC Target Search Period: Legal Obligations and Extension Mechanics

The SPAC's certificate of incorporation specifies a deadline by which a business combination must be completed or the SPAC must liquidate and return trust proceeds to shareholders. Most SPACs have initial deadlines of 18 to 24 months from the IPO date, with an option to extend the deadline for one or more additional periods subject to shareholder approval and, in many structures, a per-extension payment into the trust by the sponsor. The search period deadline creates a structural pressure on sponsors to identify and announce a transaction before the extension mechanism is exhausted, which can lead sponsors to accept less favorable terms with target companies or to pursue targets at inflated valuations simply to avoid triggering liquidation.

During the search period, the SPAC is a reporting company under the Securities Exchange Act and must file periodic reports on Forms 10-K and 10-Q, proxy statements for any required shareholder votes, and current reports on Form 8-K disclosing material events. The SPAC's periodic disclosure obligations during the search period are relatively straightforward because the SPAC has no operations, but they require legal oversight to ensure that the SPAC does not make disclosure errors or engage in communications about potential targets that violate Regulation FD or trading restrictions applicable to SPAC insiders.

Extension votes are a common feature of the post-2022 SPAC market, as many SPACs formed during the 2020-2021 boom did not identify suitable targets within their initial deadlines. Extension votes typically require the SPAC to hold a shareholder meeting to approve the charter amendment extending the deadline, and many SPAC charters condition the extension on the sponsor depositing a specified amount per share (often $0.033 to $0.10 per month) into the trust account as consideration for asking shareholders to extend rather than liquidate. Counsel should understand the extension mechanics in the SPAC's charter and trust agreement before advising a target company that is evaluating whether the SPAC has sufficient runway to complete the de-SPAC process within its structural constraints.

7. Letter of Intent and Exclusivity

The LOI in a SPAC transaction serves the same initial function as an LOI in a traditional M&A deal: it establishes the principal economic terms, structure, and exclusivity period within which the parties will negotiate a definitive agreement. Key LOI provisions specific to SPAC transactions include the implied enterprise value of the target, the form and amount of consideration (typically a combination of combined company stock, earnout shares, and rollover of existing target equity), the sponsor's promote structure and any agreed forfeiture or adjustment provisions, the minimum cash condition at closing, and the target's obligation to cooperate with PCAOB audit preparation and Form S-4 disclosure. Because SPAC transactions move from LOI to announcement on a relatively compressed timeline, the LOI carries more negotiating weight than in many traditional M&A processes.

Exclusivity provisions in SPAC LOIs typically run 30 to 60 days from LOI execution, with mutual extension rights subject to agreed conditions. Target companies that grant exclusivity to a SPAC should understand that the exclusivity period will coincide with significant internal investment in PCAOB audit preparation, financial statement restatement if required, data room organization, and management time commitment to the de-SPAC process. If the transaction fails to close after the target has incurred these costs, the target may have limited remedies absent a specific break fee provision in the LOI or definitive agreement, because SPAC transaction failure risk is distributed differently than in a traditional M&A deal where the buyer puts meaningful capital at risk on signing.

Target boards should obtain a fairness opinion or valuation analysis as part of their evaluation of the LOI terms, both to satisfy their fiduciary duties under applicable state law and to create a record that supports the disclosure to target shareholders regarding the fairness of the transaction consideration. The fairness opinion process should begin early in the LOI negotiation period, because SPAC transaction timelines do not accommodate the sequential process that is common in traditional M&A transactions, and a delayed or unsatisfactory fairness opinion can become an obstacle to the shareholder vote that cannot be resolved quickly.

8. De-SPAC Business Combination Process

The de-SPAC business combination is a merger, stock purchase, or asset acquisition that results in the SPAC's public registration inuring to the operating business. The most common structure is a forward merger in which the target company merges with and into a wholly-owned subsidiary of the SPAC (or the SPAC merges with and into the target), with the surviving entity becoming a subsidiary of the combined public company. This structure allows the SPAC's existing exchange listing and CUSIP to be transferred to the combined company, avoiding the delays and costs of a new listing application, but it requires that the combined company satisfy the exchange's initial listing standards as of the closing date, which in a high-redemption scenario may require additional PIPE financing to meet the minimum market capitalization threshold.

The definitive business combination agreement is substantially more complex than a traditional private company M&A agreement because it must address the SPAC's contractual obligations to its public shareholders, the mechanics of the trust account release, the conditions to closing that protect the target against a failed PIPE or excessive redemptions, and the post-closing governance arrangements for the combined company. Key negotiated provisions include representations and warranties on the SPAC's capitalization and absence of undisclosed liabilities, conditions related to minimum cash at closing after redemptions and PIPE proceeds, requirements related to exchange listing approval, the form of surviving corporation or limited liability company, the composition of the combined company's board and executive management team, and any earnout or earnback provisions applicable to target or sponsor equity.

From announcement to closing, the de-SPAC process requires parallel workstreams that must be coordinated by counsel across SPAC counsel, target counsel, underwriter counsel, PIPE investor counsel, financial advisors, and the PCAOB auditor. The critical path typically runs through the target's financial statement preparation and SEC review of the Form S-4, which is the most time-consuming and unpredictable element of the process. Counsel experienced in de-SPAC transactions should establish a realistic timeline at announcement that accounts for two rounds of SEC review, possible auditor re-staffing delays, and the lead time required to organize and conduct the shareholder vote, typically four to six weeks after the Form S-4 is declared effective.

9. Form S-4 and Proxy Statement Structure

The Form S-4 registration statement is the primary disclosure document for a de-SPAC business combination that involves issuing SPAC shares as merger consideration to target shareholders. The S-4 registers the combined company shares to be issued in the transaction and also functions as a proxy statement soliciting SPAC shareholder approval of the business combination. The document must include the description of the target business and its financial statements, the description of the SPAC and its capitalization, a detailed description of the business combination agreement and its material terms, management's discussion and analysis of the target's historical financial results and pro forma combined financial statements, risk factors specific to the combined company, and the sponsor's material interests in the transaction including the promote economics and any conflicts of interest.

Where the de-SPAC transaction is structured as a tender offer rather than a merger requiring a shareholder vote, the SPAC files a Schedule TO under the Williams Act rather than a Form S-4 with a proxy component, and the target files a Schedule 14D-9 recommendation statement. This structure is discussed further in Section 15, but from a disclosure preparation perspective, counsel should understand that the SEC's review standards for SPAC proxy and S-4 filings have become significantly more rigorous following the 2024 SPAC Rules, with particular scrutiny directed at sponsor compensation disclosure, dilution analysis, projection disclosure, and fairness discussion.

Under the 2024 SPAC Rules, the target company is required to be named as a co-registrant on the Form S-4, which means the target's management team assumes Section 11 liability for material misstatements or omissions in the registration statement. This is a structural change from prior practice where the target provided information for the S-4 but was not formally a registrant, and it requires target management to apply the same level of due diligence to the S-4's accuracy that would be required of management in a traditional IPO registration statement on Form S-1.

10. Financial Statement Requirements: Target Audits, PCAOB Compliance, and Pro Forma

The target company's financial statements included in the Form S-4 must satisfy SEC financial statement requirements as if the target were a registrant conducting its own IPO. This means the financial statements must be audited by a PCAOB-registered accounting firm under PCAOB auditing standards, which is a materially more demanding standard than the generally accepted auditing standards used by most private company audit firms. The number of years of audited financial statements required depends on whether the target constitutes a significant acquisition under Regulation S-X Rule 3-05, which is determined by applying significance tests based on the relative investment, asset, and income size of the target compared to the SPAC. Most de-SPAC targets of meaningful size require two years of PCAOB-audited financial statements and interim periods.

In addition to the target's standalone financial statements, the Form S-4 must include pro forma financial statements for the combined company that reflect the business combination, including the effect of PIPE financing proceeds, trust account withdrawals for redemptions, deferred underwriting commission payment, and any purchase accounting adjustments arising from the transaction's accounting treatment. SPAC business combinations are typically accounted for as reverse mergers in which the target is treated as the accounting acquirer, which means the combined company's historical financial statements presented in subsequent Exchange Act filings will be those of the target, not the SPAC. The pro forma presentation must comply with Article 11 of Regulation S-X and reflect a range of assumptions about redemption levels that are disclosed in the S-4.

Companies that have not previously used a PCAOB-registered auditor should initiate the transition to PCAOB-compliant auditing as early as possible in the de-SPAC process, ideally before the LOI is signed. The re-audit process for prior years under PCAOB standards can surface accounting issues, revenue recognition questions, and internal control deficiencies that were not identified under a less rigorous audit standard. These issues, if discovered during Form S-4 preparation, can delay the SEC review process by months and in some cases require restatement of financial statements that have already been disclosed to the market through the deal announcement, creating both disclosure obligations and litigation exposure.

11. PIPE Financing Mechanics: Common PIPE, Convertible PIPE, and Forward Purchase Agreements

A common PIPE involves the sale of combined company shares to institutional investors at a negotiated price, typically at or near $10 per share, in a private placement that closes simultaneously with the de-SPAC business combination. The PIPE investors receive registration rights requiring the combined company to file a resale registration statement within a specified period (typically 30 days) after closing, and the PIPE purchase agreement includes representations and warranties, covenants, and closing conditions similar to those in any private placement. The PIPE size is typically calibrated to ensure that the combined company will have sufficient cash to meet the minimum cash condition in the business combination agreement even if public share redemptions are at the high end of management's projected range.

Convertible PIPE structures involve the issuance of preferred stock or convertible notes to PIPE investors rather than common shares, which allows investors to obtain a senior economic position relative to common equity while retaining conversion upside. Convertible PIPEs became more common in the post-2022 environment as institutional investors became more skeptical of de-SPAC transaction valuations and demanded structural protections that common equity does not provide. From the combined company's perspective, convertible PIPE instruments can create significant overhang on the common stock, as investors holding conversion rights may sell converted shares into the market when the stock trades above the conversion price, depressing the public float in the period immediately following the de-SPAC closing.

A forward purchase agreement (FPA) is a commitment made at the time of the SPAC IPO by the sponsor or an affiliated fund to purchase a specified number of combined company shares at $10 per share at the de-SPAC closing, regardless of redemption levels. FPAs are disclosed in the SPAC's IPO registration statement and trust agreement, and they represent committed capital that reduces the PIPE financing burden at the de-SPAC stage. However, FPAs often include conditions that permit the FPA investor to decline to fund if certain conditions are not met, including conditions related to the target's financial condition, the size of public share redemptions, or the terms of the business combination agreement, and counsel must review these conditions carefully to assess how reliable the FPA commitment actually is in the context of a specific de-SPAC transaction.

12. Redemption Pressure and Threshold Structures

Redemption pressure is the defining execution risk in a de-SPAC transaction, and managing it requires a combination of structural protections in the business combination agreement, market outreach to potential non-redemption agreement counterparties, and PIPE financing sized to cover the realistic high end of the redemption range. The business combination agreement typically includes a minimum cash condition that gives the target the right to terminate the transaction if, after redemptions and PIPE proceeds are calculated, the combined company will have less than a specified cash amount at closing. This condition protects the target from being forced to proceed with a transaction that would leave it undercapitalized as a public company.

Non-redemption agreements (NRAs) are contractual commitments from existing SPAC shareholders to refrain from exercising their redemption rights in exchange for consideration, typically a portion of the sponsor's founder shares. An NRA effectively transfers economic value from the sponsor to the consenting shareholder in exchange for certainty of non-redemption, reducing the redemption risk facing the combined company at closing. NRAs must be disclosed in the proxy statement or S-4 filing, and the SEC has scrutinized NRA arrangements for compliance with disclosure requirements and for potential implications under Regulation 14A relating to proxy solicitation.

The interaction of redemption rights, minimum cash conditions, and NRAs creates a complex closing mechanics analysis that counsel must work through carefully in the weeks leading up to the shareholder vote. It is common for the parties to run a redemption scenario model that calculates the closing cash position under multiple redemption rate assumptions (30 percent, 50 percent, 70 percent, 90 percent) and tests whether each scenario satisfies the minimum cash condition after accounting for PIPE proceeds, trust interest, NRA commitments, deferred underwriting commissions, and transaction expenses. This analysis determines whether additional NRAs or supplemental PIPE financing are required and how much additional runway the parties have before the minimum cash condition becomes a deal termination risk.

13. Sponsor Promote Adjustments: Forfeiture, Earn-Back, and Price Hurdle Structures

The pressure to reform SPAC sponsor economics following the 2022 correction, combined with the SEC's 2024 disclosure requirements mandating granular disclosure of sponsor compensation and conflicts, has made promote adjustments a standard negotiating topic in de-SPAC transactions. The most common structure requires a portion of founder shares to be placed in escrow at closing, subject to release only if the combined company's stock reaches specified volume-weighted average price hurdles within a defined measurement period. Typical structures use two or three price hurdles: a first tranche releasing at $12.50 per share, a second at $15 per share, and in some structures a third at $17.50 or $20 per share, each requiring the stock to trade at or above the threshold for 20 trading days within a 30-trading-day window during the measurement period.

From a legal documentation perspective, promote adjustment provisions must address a range of scenarios including change of control transactions after closing, stock splits and dividends that would affect the price hurdle calculations, and the treatment of forfeited shares when the measurement period expires without the relevant hurdle being reached. Counsel should also consider whether the price hurdles interact with earnout provisions issued to target shareholders, because a combined company that has both sponsor price hurdle provisions and target shareholder earnouts is subject to a complex array of potential dilutive events that must be disclosed in the S-4 and managed on an ongoing basis after closing.

Earn-back structures, in which forfeited founder shares are held in a reserve and returned to the sponsor if the stock later reaches the applicable threshold, are an alternative to permanent forfeiture that maintains the sponsor's theoretical upside while still reducing near-term dilution. The accounting treatment of unvested or escrowed founder shares under ASC 718 or other applicable guidance must be analyzed at closing and disclosed in the combined company's initial Form 10-K, because these instruments may be treated as compensatory equity that generates stock-based compensation expense over the measurement period, affecting reported earnings and potentially triggering SEC comment letters if the accounting treatment is not clearly supported.

14. Shareholder Vote Process

The SPAC shareholder vote on the business combination is the proximate event at which public shareholders exercise their redemption rights, and the logistics of the vote require careful coordination between the SPAC's transfer agent, proxy solicitor, exchange, and legal counsel. Following SEC declaration of the Form S-4 or proxy statement as effective, the SPAC mails notice and access notification to record holders and establishes a record date for voting and redemption elections. The shareholder meeting is typically held 20 to 30 days after the mailing date, providing shareholders with adequate time to evaluate the transaction and submit redemption elections.

The voting standard for SPAC business combination approval is set by the SPAC's charter, which typically requires approval of a majority of Class A shares voted at the meeting for the business combination proposal. The charter may also include a supermajority vote requirement for charter amendments required to consummate the combination, or for approval of the conversion of Class B founder shares to Class A shares at closing. If the SPAC's charter imposes a requirement that a majority of the total outstanding shares, rather than a majority of shares voted, approve the combination, the quorum and vote logistics become significantly more complicated and the risk of a failed vote increases.

Proxy solicitor engagement is standard in de-SPAC shareholder votes, and the proxy solicitor plays an active role in contacting record and beneficial holders to confirm voting intentions, encourage participation to ensure quorum, and, where NRAs are in place, confirm that consenting holders are complying with their non-redemption commitments. Counsel should coordinate with the proxy solicitor and transfer agent throughout the pre-vote period to maintain a running redemption estimate, because the parties need adequate notice of a potential minimum cash condition failure to activate remediation strategies such as supplemental PIPE commitments or additional NRAs.

15. Williams Act Tender Offer Alternative to the Shareholder Vote

As an alternative to the proxy vote structure, the SPAC may structure the de-SPAC business combination as a tender offer under Sections 14(d) and 14(e) of the Securities Exchange Act (the Williams Act). In a tender offer structure, the combined company or the SPAC offers to purchase Class A shares from public shareholders at the trust account per-share amount, with tendered shares funded from the trust account and non-tendered shares converting into combined company shares at the closing of the business combination. This structure can be faster than the proxy vote structure because the tender offer can be completed in 20 to 40 business days from commencement without the Form S-4 and SEC review process required for a registered share issuance, although the business combination agreement itself may still require registration on a shorter form if the SPAC is issuing registered combined company shares to target shareholders.

The principal legal consideration in choosing the tender offer structure is whether the de-SPAC transaction requires registration of the shares issued as consideration to target shareholders. If target shareholders receive registered combined company shares in the merger, a Form S-4 is required regardless of whether the public shareholder liquidity event is structured as a tender offer or a vote, eliminating some of the speed advantage of the tender offer approach. The tender offer structure may be particularly useful where the target company shareholders are receiving primarily cash consideration or where the transaction is structured as a stock purchase rather than a merger, avoiding the Form S-4 requirement and streamlining the SEC review process.

Under the 2024 SPAC Rules, the SEC has clarified that the substantive disclosure requirements applicable to de-SPAC transactions, including enhanced sponsor compensation disclosure, dilution analysis, and projection disclosure standards, apply regardless of whether the transaction is structured as a shareholder vote or a tender offer. Counsel choosing between structures should therefore not view the tender offer as an approach to reduced disclosure obligations but rather as a potential timing advantage in appropriate transaction structures where the SEC review burden is not meaningfully different from the shareholder vote path.

16. SEC 2024 SPAC Rules: Projection Safe Harbor Loss, Forward-Looking Liability, Co-Registrant Treatment, and Investor Protection

The SEC adopted its SPAC-related rules package in January 2024, effective July 2024, representing the Commission's most significant intervention in the SPAC market since SPACs became a mainstream vehicle in 2019. The centerpiece of the 2024 Rules is the elimination of the argument that de-SPAC transactions qualified for the PSLRA safe harbor for forward-looking statements that is available for certain business combinations. Prior to the 2024 Rules, SPAC transactions relied on this safe harbor (or its analogue under the Securities Act's Rule 175) to include management projections in proxy statements and Form S-4 filings with a protective disclaimer, knowing that the PSLRA's safe harbor would shield those projections from securities fraud claims if the projections proved overly optimistic. The 2024 Rules confirm that this safe harbor does not apply to de-SPAC transactions, subjecting projections to the same liability standards as projections in a traditional IPO registration statement.

The co-registrant treatment requirement mandates that the target company be named as a co-registrant on any Form S-4 filed in connection with a de-SPAC transaction, which imposes on the target's CEO and CFO the same certification obligations that apply to the SPAC's officers. This change means that the target's management team must be prepared to sign the Section 302 and Section 906 certifications attesting to the accuracy of the registration statement and take on the personal liability exposure that attaches to those certifications. Target management that is unfamiliar with the disclosure obligations of a public company registration statement requires orientation by counsel before executing these certifications.

Additional provisions of the 2024 Rules require enhanced disclosure of all forms of sponsor compensation, including deferred underwriting commissions, private placement warrant terms, forward purchase agreements, and any arrangements between the sponsor and third parties that relate to the SPAC or the business combination. The rules also require disclosure of any material conflicts of interest, including situations in which the sponsor or its affiliates have financial relationships with the target or with PIPE investors that could affect the sponsor's incentives in negotiating the transaction terms. These disclosure requirements effectively codify the SEC's prior comment letter practice and impose them as bright-line rules, reducing the negotiating flexibility that previously existed around disclosure scope.

17. Section 11 Liability for Target Management

Section 11 of the Securities Act of 1933 imposes liability on signatories and certain other participants in a registration statement for material misstatements or omissions in that document, with no requirement that the plaintiff prove scienter or reliance. Under the 2024 SPAC Rules' co-registrant treatment, the target company and its management are now signatories to the Form S-4, which means that a purchaser of SPAC shares registered on the S-4 who suffers a loss may bring a Section 11 claim against target management based on a material misstatement or omission anywhere in the registration statement, including sections describing the SPAC or the business combination terms that target management did not draft.

The due diligence defense to Section 11 liability requires that a defendant who is not an expert have, after reasonable investigation, reasonable grounds to believe and have believed that the non-expertised portions of the registration statement were accurate and did not omit material information. For target management who are new to SEC disclosure practices and are being asked to sign a complex Form S-4 that includes SPAC financial information, sponsor economics, and pro forma combined financial statements, the "reasonable investigation" standard requires a substantial investment of management time and legal guidance before the certification is executed. Counsel should conduct a formal due diligence review process with target management, similar to a comfort letter process with the underwriter in a traditional IPO, to build the evidentiary record supporting a due diligence defense.

Directors and officers liability insurance for the combined company should be evaluated with the 2024 SPAC Rules' Section 11 exposure in mind. The D&O policy for the combined company at closing should cover target management's retroactive exposure for the Form S-4 registration statement, not merely their prospective exposure for post-closing Exchange Act filings, and the tail coverage period should extend far enough to cover the three-year statute of limitations for Section 11 claims. Insurance brokers and D&O counsel should be engaged well before the business combination closing to ensure that coverage is in place at the moment the Form S-4 is declared effective.

18. Dissenters and Appraisal Rights in De-SPAC Transactions

Appraisal rights under Delaware General Corporation Law Section 262 are potentially available to stockholders of a constituent corporation in a statutory merger, but their practical relevance in de-SPAC transactions differs substantially for SPAC shareholders and target shareholders. SPAC public shareholders have a redemption right that provides a more certain and financially equivalent remedy to appraisal: they can exchange their Class A shares for the trust account per-share value regardless of how they vote on the business combination, without the litigation risk and delay inherent in an appraisal proceeding. Because the redemption mechanism is faster, more certain, and produces a known return rather than an uncertain court-determined value, SPAC shareholders who are dissatisfied with the transaction terms almost always redeem rather than seek appraisal.

Target company shareholders in a de-SPAC merger present a different appraisal analysis. If the target is a Delaware corporation and the business combination is structured as a merger, target shareholders who do not vote in favor of the merger and comply with the perfection requirements of DGCL Section 262 may have appraisal rights to obtain the court-determined fair value of their shares. The practical significance of this right depends on whether the target shareholders are receiving combined company stock, cash, or a mix: shareholders receiving publicly traded combined company stock at closing may be excluded from appraisal rights under the market-out exception if the consideration meets the applicable requirements, while shareholders receiving cash in a cash-out merger structure typically retain appraisal rights regardless.

Counsel should analyze the appraisal right exposure for target shareholders in the specific transaction structure and include appropriate disclosure in the proxy statement or information statement provided to target shareholders. If a significant portion of the target's shareholders are sophisticated private equity or venture capital investors who are familiar with appraisal litigation as a valuation arbitrage strategy, the business combination agreement should address the treatment of appraisal claims and whether appraisal exposure will be covered by the target's indemnification obligations or treated as an additional form of consideration that reduces the total equity value distributed to target shareholders at closing.

19. Post-De-SPAC Public Company Obligations and Going-Private Considerations

The combined company that emerges from a de-SPAC transaction assumes the full suite of Exchange Act reporting obligations as a registered public company, identical in scope to those of a company that completed a traditional IPO. These obligations include quarterly reports on Form 10-Q, annual reports on Form 10-K with PCAOB-audited financial statements and management's assessment of ICFR under SOX Section 404(a), current reports on Form 8-K for material events, proxy statements for annual and special shareholder meetings, and the full governance framework required by the listing exchange including board independence, audit committee composition, and code of ethics. The speed of the SPAC path to public markets does not reduce any of these obligations, and combined companies that have not built internal compliance infrastructure before the de-SPAC closing will face immediate challenges in meeting their first quarterly filing deadlines.

Going-private considerations arise for de-SPAC companies whose stock trades persistently below $10 per share after closing, making the public company compliance cost burden disproportionate to the capital markets benefits of public company status. A combined company with a small public float, high redemption rates that left the trust essentially depleted, and a stock price in the $2 to $5 range may find that the annual cost of Exchange Act compliance, PCAOB audits, D&O insurance, and governance infrastructure exceeds $5 million, representing a significant burden for a company of that size. Rule 13e-3 going-private transactions, tender offers by controlling shareholders, and reverse stock splits to reduce the registered shareholder count below the Section 12(g) registration threshold are all structures that counsel may need to analyze for de-SPAC companies in financial distress.

The post-de-SPAC transition period, typically the first 12 months following closing, requires coordinated attention from management, outside counsel, accounting advisors, and investor relations personnel. Critical tasks during this period include filing the resale registration statements for PIPE investors and holders of registered securities under the registration rights agreement, establishing Section 16 compliance procedures for officers and directors, implementing an insider trading policy and pre-clearance process, completing the first SOX 404 assessment for the annual report, and preparing the combined company's first proxy statement for the annual meeting of stockholders. Companies that entered the de-SPAC process without adequate preparation for this transition period consistently experience compliance deficiencies that generate SEC comment letters and expose management to insider trading or Section 16 reporting violations.

20. Earnouts, Escrow, SPAC Litigation Patterns, and the Role of Counsel

Earnout provisions in de-SPAC transactions allocate additional combined company shares to target shareholders if the combined company's stock reaches specified price thresholds, typically above the $10 trust value, within a defined measurement period after closing. Earnouts serve a valuation gap-bridging function similar to their role in private M&A transactions, but in a SPAC context they also address the uncertainty inherent in bringing a private company to public markets at a valuation that depends heavily on management's forward projections. Earnout terms must be disclosed fully in the Form S-4, including the price thresholds, measurement periods, and any conditions that could accelerate or eliminate the earnout, and the accounting treatment of earnout shares under applicable GAAP guidance must be determined and disclosed in the initial registration statement.

SPAC litigation has clustered around three recurring fact patterns in the post-2022 period. The first is warrant accounting: the SEC issued guidance in 2021 concluding that many SPAC warrants should be classified as liabilities rather than equity instruments under ASC 815, requiring restatement of financial statements for hundreds of SPACs that had classified warrants as equity. The second is projection disputes: plaintiff firms have successfully argued that management projections included in de-SPAC proxy statements and S-4 filings constituted fraudulent misrepresentations when the combined company failed to achieve projected results, with the Multiplan Corp. decision in the Delaware Court of Chancery establishing that target management and sponsor have fiduciary disclosure duties to SPAC shareholders that extend to projections underlying the fairness analysis. The third is sponsor conflict disclosure: cases alleging that sponsors failed to disclose the full extent of their compensation and conflicts of interest have become a staple of SPAC class action practice, particularly where the sponsor had financial relationships with the target or PIPE investors that were not fully disclosed in the proxy materials.

The role of counsel in a SPAC transaction encompasses the full arc from SPAC formation through de-SPAC closing and into the combined company's early quarters as a reporting company. Sponsor counsel advises on SPAC IPO structuring, negotiate the promote and at-risk capital economics with the underwriter, manages the target search and LOI process, and represents the sponsor in the business combination negotiation. Target counsel approaches the de-SPAC as an M&A and securities transaction combined: advising the target board on fiduciary duties in evaluating the transaction, negotiating the business combination agreement, coordinating the PCAOB audit and financial statement preparation, managing the Form S-4 co-registrant obligations under the 2024 Rules, and advising target management on the Section 11 liability exposure that attaches to the registration statement certifications. The legal complexity of a SPAC transaction, spread across M&A documentation, Securities Act registration, Exchange Act proxy compliance, and post-closing reporting infrastructure, requires counsel with SPAC-specific experience across all three dimensions, not merely general M&A or securities expertise.

Frequently Asked Questions